Changes to the Code
H.R. 2075 · Protecting Life and Integrity in Research Act of 2025 · Introduced The text as a member of Congress first filed it. Most bills never get further than this.
In committee · step 2 of 5
42 U.S.C. § 289g–1 Research on transplantation of fetal tissue
7 changes the bill asks for here, 6 carried out
- Carried out:
in the section heading, by striking
transplantation of fetal tissue
and insertinghuman fetal tissue obtained after a miscarriage or stillbirth
; - Carried out:
by amending subsection (a) to read as follows:
(a) Establishment of program.— The Secretary may conduct or support research on human fetal tissue obtained after a miscarriage or a stillbirth.;
- Carried out:
in paragraph (1)(B), by inserting
if the human fetal tissue is intended for transplantation,
beforethe donation
; and - Carried out:
by striking subparagraph (A); and
- Not carried out:
by redesignating subparagraphs (B) and (C) as (A) and (B), respectively;
We can't read how this instruction is worded yet, so it isn't shown in the text.
Technical detail
no-pattern: redesignating subparagraphs (X) and (X) as (X) and (X), respectively; - Carried out:
in subsection (c)(1)(B), by striking
pursuant to a spontaneous or induced abortion or pursuant to
and insertingafter a miscarriage or
; and - Carried out:
by amending subsection (g) to read as follows:
(g) Definitions.— In this section: (1) Human fetal tissue.— The term “human fetal tissue” means tissue or cells obtained from a dead unborn child pursuant to an induced abortion, a miscarriage, or a stillbirth. (2) Miscarriage.— The term “miscarriage” means the involuntary death …
§ 289g–1(a)–(b)
| Where | Mark | The Code now | Mark | As the bill would leave it |
|---|---|---|---|---|
| § 289g–1. Research on | § 289g–1. Research on [inserted: human] fetal tissue[inserted: obtained after a miscarriage or stillbirth] | |||
| (a) | (a) Establishment of program | (a) Establishment of program[inserted: .—] | ||
| [inserted: The Secretary may conduct or support research on human fetal tissue obtained after a miscarriage or a stillbirth.] | ||||
| (a)(1) | (1) | |||
| (a)(2) | (2) | |||
| (b) | (b) Informed consent of donor | (b) Informed consent of donor | ||
| (b)(1) | (1) In general | (1) In general | ||
| In research carried out under subsection (a), human fetal tissue may be used only if the woman providing the tissue makes a statement, made in writing and signed by the woman, declaring that— | In research carried out under subsection (a), human fetal tissue may be used only if the woman providing the tissue makes a statement, made in writing and signed by the woman, declaring that— | |||
| (b)(1)(A) | (A) | (A) | ||
| the woman donates the fetal tissue for use in research described in subsection (a); | the woman donates the fetal tissue for use in research described in subsection (a); | |||
| (b)(1)(B) | (B) | (B) | ||
| the donation is made without any restriction regarding the identity of individuals who may be the recipients of transplantations of the tissue; and | [inserted: if ]the [inserted: human fetal tissue is intended for transplantation, the ]donation is made without any restriction regarding the identity of individuals who may be the recipients of transplantations of the tissue; and | |||
| (b)(1)(C) | (C) | (C) | ||
| the woman has not been informed of the identity of any such individuals. | the woman has not been informed of the identity of any such individuals. | |||
| (b)(2) | (2) Additional statement | (2) Additional statement | ||
| In research carried out under subsection (a), human fetal tissue may be used only if the attending physician with respect to obtaining the tissue from the woman involved makes a statement, made in writing and signed by the physician, declaring that— | In research carried out under subsection (a), human fetal tissue may be used only if the attending physician with respect to obtaining the tissue from the woman involved makes a statement, made in writing and signed by the physician, declaring that— | |||
| (b)(2)(A) | (A) | |||
| (b)(2)(A)(i) | (i) | |||
| (b)(2)(A)(ii) | (ii) | |||
| (b)(2)(A)(iii) | (iii) | |||
| (b)(2)(B) | (B) | (B) | ||
| the tissue has been donated by the woman in accordance with paragraph (1); and | the tissue has been donated by the woman in accordance with paragraph (1); and | |||
| (b)(2)(C) | (C) | (C) | ||
| full disclosure has been provided to the woman with regard to— | full disclosure has been provided to the woman with regard to— | |||
§ 289g–1(c)Informed consent of researcher and donee(1)–(2)
(b)(2)(C)(i)–(c)(1) unchanged
| Where | Mark | The Code now | Mark | As the bill would leave it |
|---|---|---|---|---|
| (1)(A) | (A) | (A) | ||
| the tissue is human fetal tissue; | the tissue is human fetal tissue; | |||
| (1)(B) | (B) | (B) | ||
| the tissue may have been obtained | the tissue may have been obtained [inserted: after] a [inserted: miscarriage] or a stillbirth; and | |||
| (1)(C) | (C) | (C) | ||
| the tissue was donated for research purposes; | the tissue was donated for research purposes; | |||
| (2) | (2) | (2) | ||
| has provided such information to other individuals with responsibilities regarding the research; | has provided such information to other individuals with responsibilities regarding the research; |
§ 289g–1(e)–(g)
(c)(3)–(e)(1) unchanged
| Where | Mark | The Code now | Mark | As the bill would leave it |
|---|---|---|---|---|
| (e)(2) | (2) Research conducted by Secretary | (2) Research conducted by Secretary | ||
| The Secretary may conduct research under subsection (a) only in accordance with applicable State and local law. | The Secretary may conduct research under subsection (a) only in accordance with applicable State and local law. | |||
| (f) | (f) Report | (f) Report | ||
| The Secretary shall annually submit to the Committee on Energy and Commerce of the House of Representatives, and to the Committee on Labor and Human Resources of the Senate, a report describing the activities carried out under this section during the preceding fiscal year, including a description of whether and to what extent research under subsection (a) has been conducted in accordance with this section. | The Secretary shall annually submit to the Committee on Energy and Commerce of the House of Representatives, and to the Committee on Labor and Human Resources of the Senate, a report describing the activities carried out under this section during the preceding fiscal year, including a description of whether and to what extent research under subsection (a) has been conducted in accordance with this section. | |||
| (g) | (g) | (g) [inserted: Definitions.—] | ||
| [inserted: In this section:] | ||||
| (g)(1) | (1) [inserted: Human fetal tissue.—] | |||
| [inserted: The term “human fetal tissue” means tissue or cells obtained from a dead unborn child pursuant to an induced abortion, a miscarriage, or a stillbirth.] | ||||
| (g)(2) | (2) [inserted: Miscarriage.—] | |||
| [inserted: The term “miscarriage” means the involuntary death of an unborn child who was carried in the womb for a period of less than 20 weeks.] | ||||
| (g)(3) | (3) [inserted: Stillbirth.—] | |||
| [inserted: The term “stillbirth” means the involuntary death of an unborn child who was carried in the womb for a period of 20 weeks or more.] | ||||
| (g)(4) | (4) [inserted: Unborn child.—] | |||
| [inserted: The term “unborn child” has the meaning given such term in section 1841(d) of title 18, United States Code.] | ||||
| (g) | ||||
42 U.S.C. § 289g–2 Prohibitions regarding human fetal tissue
5 changes the bill asks for here, 5 carried out
- Carried out:
Section 498B(c)(1) of the Public Health Service Act (42 U.S.C. 289g–2(c)(1)) is amended to read as follows:
(1) solicit or knowingly acquire, receive, or accept a donation (excluding any transfer for purposes of autopsy or burial) of human fetal tissue knowing that— (A) a human pregnancy was deliberately initiated to provide such tissue; or (B) the tissue was obtained pursuant to an induced abortion; or.
- Carried out:
by striking subsection (b);
- Carried out:
by redesignating subsections (c) through (e) as subsections (b) through (d), respectively; and
- Carried out:
in paragraph (1), by striking
(a), (b), or (c)
and inserting(a) or (b)
; and - Carried out:
in paragraph (2), by striking
or (b)(3)
.
§ 289g–2(a)–(d)
| Where | Mark | The Code now | Mark | As the bill would leave it |
|---|---|---|---|---|
| § 289g–2. Prohibitions regarding human fetal tissue | § 289g–2. Prohibitions regarding human fetal tissue | |||
| (a) | (a) Purchase of tissue | (a) Purchase of tissue | ||
| It shall be unlawful for any person to knowingly acquire, receive, or otherwise transfer any human fetal tissue for valuable consideration if the transfer affects interstate commerce. | It shall be unlawful for any person to knowingly acquire, receive, or otherwise transfer any human fetal tissue for valuable consideration if the transfer affects interstate commerce. | |||
| (b) | (b) | |||
| (b)(1) | (1) | |||
| (b)(2) | (2) | |||
| (b)(3) | (3) | |||
| (b) | [inserted: (b)] Solicitation or acceptance of tissue from fetuses gestated for research purposes | |||
| It shall be unlawful for any person or entity involved or engaged in interstate commerce to— | It shall be unlawful for any person or entity involved or engaged in interstate commerce to— | |||
| (b)(1) | (1) | (1) | ||
| [inserted: solicit or knowingly acquire, receive, or accept a donation (excluding any transfer for purposes of autopsy or burial) of human fetal tissue knowing that—] | ||||
| (b)(1)(A) | (A) [inserted: ] | |||
| [inserted: a human pregnancy was deliberately initiated to provide such tissue; or] | ||||
| (b)(1)(B) | (B) [inserted: ] | |||
| [inserted: the tissue was obtained pursuant to an induced abortion; or] | ||||
| (c)(1) | ||||
| (b)(2) | (2) | (2) | ||
| knowingly acquire, receive, or accept tissue or cells obtained from a human embryo or fetus that was gestated in the uterus of a nonhuman animal. | knowingly acquire, receive, or accept tissue or cells obtained from a human embryo or fetus that was gestated in the uterus of a nonhuman animal. | |||
| (c) | [inserted: (c)] Criminal penalties for violations | |||
| (c)(1) | (1) In general | (1) In general | ||
| Any person who violates subsection (a) | Any person who violates subsection (a) or ([inserted: b]) shall be fined in accordance with title 18, subject to paragraph (2), or imprisoned for not more than 10 years, or both. | |||
| (c)(2) | (2) Penalties applicable to persons receiving consideration | (2) Penalties applicable to persons receiving consideration | ||
| With respect to the imposition of a fine under paragraph (1), if the person involved violates subsection (a) | With respect to the imposition of a fine under paragraph (1), if the person involved violates subsection (a), a fine shall be imposed in an amount not less than twice the amount of the valuable consideration received. | |||
| (d) | [inserted: (d)] Definitions | |||
| For purposes of this section: | For purposes of this section: | |||
| (d)(1) | (1) | (1) | ||
| The term “human fetal tissue” has the meaning given such term in section 289g–1(g) of this title. | The term “human fetal tissue” has the meaning given such term in section 289g–1(g) of this title. | |||
| (d)(2) | (2) | (2) | ||
| The term “interstate commerce” has the meaning given such term in section 321(b) of title 21. | The term “interstate commerce” has the meaning given such term in section 321(b) of title 21. | |||
| (d)(3) | (3) | (3) | ||
| The term “valuable consideration” does not include reasonable payments associated with the transportation, implantation, processing, preservation, quality control, or storage of human fetal tissue. | The term “valuable consideration” does not include reasonable payments associated with the transportation, implantation, processing, preservation, quality control, or storage of human fetal tissue. | |||